Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tadnersen (BIIB078) is an antisense oligonucleotide (ASO) designed for the selective targeting of C9ORF72 transcript variants 1 and 3, specifically those carrying the expansion.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 539.00 |
Description | Tadnersen (BIIB078) is an antisense oligonucleotide (ASO) designed for the selective targeting of C9ORF72 transcript variants 1 and 3, specifically those carrying the expansion. |
In vitro | Tadnersen (BIIB078) is an RNAse H oligomer designed to selectively target and inhibit mutant C9ORF72 transcripts. It is primarily utilized in the study of Amyotrophic Lateral Sclerosis (ALS), focusing on understanding and potentially treating this condition. |
Synonyms | IONIS-C9Rx, BIIB078 |
Molecular Weight | N/A |
CAS No. | 2170507-65-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tadnersen 2170507-65-8 BIIB-078 IONIS-C9Rx BIIB078 BIIB 078 inhibitor inhibit